С. В. Сенников

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Multimodal profiling of HER2/neu-specific TCR-T cells reveals clonotype-dependent activation programs underlying differential cytotoxic efficacy2026
• Chemokine Profiles and Immunosuppressive Properties of Murine Placental Nucleated Erythroid Cells in Mid- and Late Gestation2026
• Changes in the Metabolism of GD2-Specific Murine CAR-T Cells After Co-Culturing with Melanoma2026
• Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances2026
• T-regulatory cells for the treatment of autoimmune diseases2025
• GD2-targeting therapy: a comparative analysis of approaches and promising directions2024 · аннотациясвернуть

  Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance and repair of neural tissue is…

• TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges2024 · аннотациясвернуть

  TCR-T cell therapy represents a promising advancement in adoptive immunotherapy for cancer treatment. Despite its potential, the development and preclinical testing of TCR-T cells face significant challenges. This…

• The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?2023 · аннотациясвернуть

  Early efforts to identify tumor-associated antigens over the last decade have provided unique cancer epitopes for targeted cancer therapy. MAGE-A proteins are a subclass of cancer/testis (CT) antigens that are presented…